V Square Quantitative Management LLC Acquires 23,071 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

V Square Quantitative Management LLC grew its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 95.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 47,327 shares of the pharmacy operator’s stock after acquiring an additional 23,071 shares during the period. V Square Quantitative Management LLC’s holdings in Walgreens Boots Alliance were worth $424,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of WBA. Iron Horse Wealth Management LLC boosted its holdings in Walgreens Boots Alliance by 162.5% in the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 1,300 shares during the period. Blue Trust Inc. boosted its holdings in Walgreens Boots Alliance by 87.0% in the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 1,081 shares during the period. Continuum Advisory LLC boosted its holdings in Walgreens Boots Alliance by 71.2% in the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,020 shares during the period. Strategic Investment Solutions Inc. IL bought a new position in Walgreens Boots Alliance in the 2nd quarter worth $34,000. Finally, New Covenant Trust Company N.A. bought a new position in Walgreens Boots Alliance in the 1st quarter worth $35,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Up 1.2 %

Shares of NASDAQ WBA opened at $10.79 on Friday. The firm’s 50-day moving average price is $9.41 and its 200-day moving average price is $13.10. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $9.31 billion, a price-to-earnings ratio of -1.60, a P/E/G ratio of 1.06 and a beta of 0.70. Walgreens Boots Alliance, Inc. has a 12-month low of $8.22 and a 12-month high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. During the same period in the prior year, the company posted $0.67 EPS. The firm’s revenue for the quarter was up 5.9% on a year-over-year basis. On average, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.85 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently weighed in on WBA. Barclays upped their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday. TD Cowen decreased their price target on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Thursday, September 12th. JPMorgan Chase & Co. decreased their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research note on Friday, August 30th. UBS Group boosted their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday. Finally, Truist Financial decreased their price target on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research note on Monday, October 7th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $13.38.

Read Our Latest Stock Analysis on WBA

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.